stockrowNeumora Therapeutics, Inc. (NMRA) vs NRx Pharmaceuticals, Inc. (NRXP)
- Neumora Therapeutics, Inc. NMRA 0.50 −12.28%
- NRx Pharmaceuticals, Inc. NRXP 2.31 −7.23%
Neumora Therapeutics, Inc. and NRx Pharmaceuticals, Inc. are both Biotechnology companies. Neumora Therapeutics, Inc. and NRx Pharmaceuticals, Inc. are of similar size ($98.3M and $91.5M). Neumora Therapeutics, Inc. has the higher net margin (0.00% vs −691.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, NRx Pharmaceuticals, Inc. leads on 8 and Neumora Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | NMRA | NRXP | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 46.64% | 65.16% |
| Operating margin | 0.00% | (586.15%) | 0.00% |
| Net margin | 0.00% | (691.78%) | 0.00% |
| Free cash flow margin | 0.00% | (609.02%) | 0.00% |
| Return on equity | (187.11%) | 131.22% | (50.12%) |
| Return on assets | (121.89%) | (120.41%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack